# Single-dose Study to Evaluate the Absolute Bioavailability and Mass Balance of ONO-5788

> **NCT03849872** · PHASE1 · COMPLETED · sponsor: **Ono Pharmaceutical Co., Ltd.** · enrollment: 12 (actual)

## Conditions studied

- Acromegaly

## Interventions

- **DRUG:** ONO-5788
- **DRUG:** [14C]-ONO-5788

## Key facts

- **NCT ID:** NCT03849872
- **Lead sponsor:** Ono Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-27
- **Primary completion:** 2019-04-02
- **Final completion:** 2019-04-02
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03849872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03849872, "Single-dose Study to Evaluate the Absolute Bioavailability and Mass Balance of ONO-5788". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03849872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*